Dr Bryant on the Influence of Germline DNA Repair Mutations on Therapeutic Development in PDAC
John M. Bryant, MD, discusses how identifying germline DNA repair mutations may impact the development of targeted therapy development in PDAC.
Stay updated with breaking news from Johnm Bryant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
John M. Bryant, MD, discusses how identifying germline DNA repair mutations may impact the development of targeted therapy development in PDAC.
Pardee UNC Health Care will be increasing their focus on health care worker burnout and stress as a result of a $430,000 grant to Pardee Hospital Foundation from The Duke
Health news: Longtime Pardee surgeon retiring; Four Seasons has two honored.
The rate of the composite outcome decreased in association with increased time from COVID-19 diagnosis to surgery.
The odds of experiencing major postoperative cardiovascular morbidity are reduced with increased time from COVID-19 diagnosis to surgery.